Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia 3Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Anemia, Refractory, with Excess of Blasts 2Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Biphenotypic, Acute 1Graft vs Host Disease 1Brain Neoplasms 1Anemia, Refractory 1

Interventions

Lomustine 2Gefitinib 2Carboplatin 2trofosfamide 1tozuleristide 1entrectinib 1Vincristine 1Thiotepa 1Temozolomide 1Sunitinib 1Radiotherapy 1Methylprednisolone 1Maintenance Chemotherapy 1Magnetic Resonance Spectroscopy 1Induction Chemotherapy 1Etoposide 1Erlotinib Hydrochloride 1Diploidy 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Cholecalciferol 1Bevacizumab 1Adrenal Cortex Hormones 1AZD3759 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Brain Neoplasms × Methylprednisolone × Clear all
NCT07542288 2026-04-21

Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:

The Second Affiliated Hospital of Hainan Medical University

Phase 2/3 Not yet recruiting
400 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡